Cabaletta Bio raises $128.2 million from common stock warrant exercises

• Cabaletta Bio reported exercises of 53,090,190 common stock warrants issued in its June 2025 underwritten public offering.
• Warrants carried a $2.5 exercise price per share, expiring Sept. 12, 2026.
• 5,275,100 warrants were exercised through June 30, 2026, generating about $13.2 million in gross proceeds.
• 46,011,900 warrants were exercised from July 1, 2026 through expiration, generating about $115 million in gross proceeds.
• Aggregate gross proceeds from warrant exercises totaled about $128.2 million from issuance through expiration.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cabaletta Bio Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001759138-26-000041), on September 14, 2026, and is solely responsible for the information contained therein.